Nataliya V Uboha

9PUBLICATIONS
149CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 30, 2026
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial.

Zev A Wainberg, Gulam A Manji, Nathan Bahary

|Feb 26, 2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update.

Manish A Shah, Erin B Kennedy, Dana Deighton

|Feb 11, 2026
Tumor Matrix Proteoglycan Accumulation and Processing Alter T-cell Effector Function and the Response to Immunotherapy in Patients with Oligometastatic Colorectal Cancer.

Dustin A Deming, Sean G Kraus, Joshua Brand

|Oct 17, 2025
The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404).

Mamta Parikh, Nataliya V Uboha, Naoko Takebe

|Jan 06, 2025
Phase I/II Trial of Perioperative Avelumab in Combination With Chemoradiation in the Treatment of Stage II/III Resectable Esophageal and Gastroesophageal Junction Cancer.

Nataliya V Uboha, Mustafa M Basree, Jens C Eickhoff

|Aug 06, 2024
A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Andrew L Coveler, Matthew J Reilley, Mark Zalupski

Pageof 2

Frequent Collaborators

2 joint publications

Anwaar Saeed

2 joint publications

Anne Noonan

1 joint publications

Ruiqi Geng

1 joint publications

Yuxin Zhang